The UK has started monitoring whether clinical trial sponsors are fulfilling responsibilities to make their research open and transparent.
The UK’s Health Research Authority (HRA) has introduced a new system to measure how clinical trial sponsors are complying with their obligation to make all study results public.
The new monitoring system came into effect on 15 September and requires researchers to submit information to the HRA at...
The creation of a single national formulary for medicines prescribing that could impact industry is among the action points in the UK government’s new 10-year health plan for the National Health Service in England.
Denmark is shaking up clinical trial timelines with a new process for reviewing applications for early-phase mono-national trials that is twice as fast as the standard timelines in the EU and the UK.
Industry associations EFPIA, EUCOPE and EURORDIS have praised the European Commission’s newly launched life sciences strategy, which will see investment funnelled into improving the clinical trial ecosystem and supporting advanced therapy development.
